SLC2A1 and cancer: Furthermore, the “Warburg effect” as a cellular phenomenon in cancer cells of displaying high rates of aerobic glycolysis with overexpression of glucose transporters such as GLUT1, provides clinically validated targets for cancer treatment [4,5].